Immediate Impact

56 hit
Sub-graph 1 of 23

Citing Papers

Cardiovascular, Kidney, and Safety Outcomes With GLP-1 Receptor Agonists Alone and in Combination With SGLT2 Inhibitors in Type 2 Diabetes: A Systematic Review and Meta-Analysis
2024 Hit
Effects of semaglutide with and without concomitant SGLT2 inhibitor use in participants with type 2 diabetes and chronic kidney disease in the FLOW trial
2024 Hit
2 intermediate papers

Works of Lily Agrawal being referenced

Long-term follow-up of intensive glycaemic control on renal outcomes in the Veterans Affairs Diabetes Trial (VADT)
2017
Observation on Renal Outcomes in the Veterans Affairs Diabetes Trial
2011

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Lily Agrawal 158 55 46 35 34 17 312
Jun Lu 55 0.3× 83 1.5× 27 0.6× 20 0.6× 26 0.8× 19 326
Daniel Scarr 139 0.9× 34 0.6× 41 0.9× 42 1.2× 10 0.3× 24 322
Elena Tagliabue 51 0.3× 80 1.5× 23 0.5× 14 0.4× 16 0.5× 22 343
Giuseppe Bellini 117 0.7× 52 0.9× 19 0.4× 31 0.9× 29 0.9× 22 337
Akio Ohta 185 1.2× 65 1.2× 12 0.3× 24 0.7× 14 0.4× 20 362
Takahisa Deguchi 75 0.5× 88 1.6× 12 0.3× 12 0.3× 18 0.5× 24 291
Aditi Gupta 51 0.3× 64 1.2× 106 2.3× 31 0.9× 11 0.3× 20 343
Hui Lou 78 0.5× 64 1.2× 46 1.0× 8 0.2× 10 0.3× 28 293
E.M. Kohner 146 0.9× 41 0.7× 72 1.6× 23 0.7× 32 0.9× 11 326
Keisuke Yatsu 36 0.2× 63 1.1× 25 0.5× 50 1.4× 14 0.4× 21 262

All Works

Loading papers...

Rankless by CCL
2026